Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor dapagliflozin.
第一作者:
Serge A,Jabbour
第一单位:
Division of Endocrinology, Diabetes and Metabolic Diseases, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA. serge.jabbour@jefferson.edu
作者:
主题词
二苯甲基化合物(Benzhydryl Compounds);生物转运(Biological Transport);血糖(Blood Glucose);糖尿病, 2型(Diabetes Mellitus, Type 2);葡糖苷类(Glucosides);内环境稳定(Homeostasis);人类(Humans);降血糖药(Hypoglycemic Agents);肾(Kidney);钠-葡萄糖转运体2(Sodium-Glucose Transporter 2)
DOI
10.3810/pgm.2012.07.2569
PMID
22913895
发布时间
2021-05-04
- 浏览52

Postgraduate medicine
62-73页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文